Reduce GM to Underweight; trim 30-50% on rallies to $85-87, re-enter at $70-75
Underweight justified by three constraints preventing full exit (5.62x forward P/E floor, $22B TTM FCF/buyback bid, Q1 $2.82 EPS trough defense) but empirical record of five consecutive negative-alpha Hold calls demands directional action. H2 EPS math requires $10.77 against seasonal headwinds with 60%+ historical downside revision rates for cyclical OEMs. Hybrid gap is structural multi-year problem. Technical setup is breakdown (6+ weeks MACD bearish, RSI divergence, lower Bollinger) not coil. Macro is hostile (95% zero Fed cuts probability, 10Y at 5%, beta 1.32). Underweight captures remaining asymmetric downside without full exit; Hold risks repeating alpha-destructive pattern from 9/15, 9/14, 9/10, and 9/9 decisions.
| Position | Action |
|---|---|
| Position exceeds target weight | Trim 30-50% of target GM weight (lighter end per 9/9 reversal lesson) |
| Price rallies to $85-87 VWMA resistance zone | Scale into trim on relief bounces; avoid smashing bid at $84 |
| New trim completion initiated | Place stop-loss at $87 (above VWMA) |
| Hedging residual core position | Use short-dated 78/72 put spread through Q3 2026 earnings only; do NOT use 18-month $78 puts |
| Confirmed close below $80.06 (200 SMA) on volume >10M | Full exit residual; structural thesis invalidation |
GM's deeply depressed valuation (Forward P/E 5.62, PEG 0.31) combined with an observable earnings recovery and UBS's $114 price target creates asymmetric upside as the market fails to price in structural re-rating optionality from its software/services business.
| Indicator | Value | Signal |
|---|---|---|
| close | 84.29 | neutral |
| 10_ema | 85.62 | bearish |
| 50_sma | 84.37 | neutral |
| 200_sma | 80.06 | bullish |
| rsi | 46.19 | neutral |
| macd | 0.12 | neutral |
| macdh | -0.247 | bearish |
| boll | 85.92 | neutral |
| boll_ub | 88.04 | neutral |
| boll_lb | 83.80 | neutral |
| atr | 2.29 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful retest of 200 SMA at $80.06 with bullish reversal candles
Then: Consider re-entry with strict momentum confirmation
↩ rebuts: “The Hybrid Gap Is Existential”
EV: +34% (to $114 UBS target); 12-month target: $100+ · concedes: Short-term tape is messy with 50 SMA test; Hybrid gap is real (GM effectively sells one hybrid); Hawkish Fed is real; Q4 2025 was a disaster quarter ($3.31B net loss); TTM metrics depressed: operating margin 3.20%, net margin 1.05%, ROE 3.16%
GM at $84 is a value trap dressed up as a recovery story, with the low 5.62x forward P/E reflecting realistic market pricing of structural hybrid share losses, forward EPS cuts, truck pricing mean reversion, and consumer credit deterioration—not underappreciated upside.
EV: ~$79.55
→ vs conservative: Forward P/E of 5.62 is a dangerous value trap—not a strong buy signal—when forward EPS historically revises down 60%+ for cyclical OEMs, and H2 consensus targets require near-doubling H1 performance
→ vs conservative: Leaning on Forward P/E while ignoring hawkish Fed environment (10-year just below 5%, 95% probability of zero cuts in 2026, GM beta 1.32) that compresses consumer cyclicals harder than the broader market
→ vs conservative: Not protecting capital by holding—accepting full downside risk while foregone opportunity cost accumulates against cleaner setups
→ vs neutral: UBS $114 price target is not a reason for passive HOLD—it's a sell-side narrative reaching to justify a buy rating on a stock that already tripled while fundamentals deteriorate
→ vs neutral: Acknowledged bearish RSI divergence in own report but then defaulted to HOLD anyway—incorrrect if bearish divergence is called, waiting for 'confirmation' means buying breakdowns or selling at dead cat bounce bottoms
→ vs neutral: OnStar/Super Cruise recurring revenue multiple-expansion thesis cannot work while GM loses 19% market share to competitors with products customers actually want
→ vs conservative: Historical forward EPS revision rates for cyclical OEMs sit at 60%+ to the downside—HOLD into an earnings revision cycle with this probability is negligence, not conservatism
| vwma | 85.88 | bearish |
Support: 83.47 · 83.8 · 84.37 · 80.06 | Resistance: 85.62 · 85.92 · 87.16 · 88.04
GM technical analysis shows a consolidation/pullback phase after the stock peaked at $91.66 on 2026-07-29 and has since retraced to $84.29. Short-term momentum is bearish with MACD below signal line (histogram -0.247), price below the 10 EMA ($85.62), and bearish RSI divergence confirmed (RSI 64.6 on 2026-08-11 vs 73.74 on 2026-07-28). Critical support sits at the 50 SMA ($84.37), with the 200 SMA at $80.06 as the major long-term defense. Immediate resistance is at $85.92 (Bollinger middle band), with breakout zone at $88.04. ATR of $2.29 suggests moderate volatility (~2.7% of price), useful for stop placement.
Market Capitalization
$76.24B
Shares Outstanding
~877M
Beta
1.32
Implied Current Price
~$84.28
P/E (TTM)
37.63
Forward P/E
5.62
PEG Ratio
0.31
P/B
1.19
EPS (TTM)
$2.24
Forward EPS
$15.00
Dividend Yield
0.84%
52-Week Range
$54.33 – $91.85
50-Day MA
$84.36
200-Day MA
$80.34
Q2 2026 Revenue
$48.03B
Q2 2026 Gross Profit
$3.66B
Q2 2026 Operating Income
$1.46B
Q2 2026 Net Income
$1.31B
Q2 2026 Diluted EPS
$1.41
Q1 2026 Diluted EPS
$2.82
Q4 2025 Net Income
-$3.31B
Gross Margin
~10.2% (TTM)
Operating Margin
3.20%
Net Profit Margin
1.05%
ROE
3.16%
ROA
2.25%
Total Assets (Q2 2026)
$282.74B
Total Liabilities
$219.10B
Stockholders' Equity
$62.00B
Total Debt
$127.70B
Net Debt
$107.56B
Cash & Equivalents
$24.72B
Receivables
$61.64B
Inventory
$15.95B
Current Ratio
1.14
Debt/Equity
202%
Free Cash Flow (TTM)
$21.93B
Operating Cash Flow (Q2 2026)
$6.35B
CapEx (Q2 2026)
$5.26B
Share Repurchases (Q2 2026)
$2.00B
Dividends Paid (Q2 2026)
$0.61B
Share Count Change YoY
-8%
Working Capital (Q2 2026)
$13.2B
Total Debt Change YoY
Declined from $135.7B to $127.7B
Strengths
Concerns
GM presents a cyclical value-with-recovery thesis where TTM metrics (P/E 37.63, EPS $2.24) are temporarily depressed by Q4 2025 one-time restructuring charges, but forward metrics (P/E 5.62, PEG 0.31) point to significant undervaluation if consensus EPS recovery to $15.00 materializes. The stock is executing aggressively on capital return ($2B/quarter buybacks, 8% share count reduction YoY) while generating $21.93B TTM FCF, though trading near 52-week highs limits margin of safety.
Macro: Hawkish Fed policy regime with 95% probability of zero rate cuts in 2026 (Fed hiked at September 16 meeting), 10-year Treasury just below 5%, and 12% recession probability (creeping higher). Jamie Dimon commentary supports hawkish lean. Higher-for-longer rates + hawkish Fed is a double headwind for auto OEMs: tighter consumer credit raises monthly payments on big-ticket vehicles, and elevated yields pressure equity duration of consumer cyclical stocks. This explains consumer discretionary underperformance on hawkish headlines.